Status:
RECRUITING
The Effect of Hand Exercises on Upper Limb Volume, Quality of Life, and Hand Function in Breast Cancer Survivors
Lead Sponsor:
Texas Woman's University
Collaborating Sponsors:
Presbyterian Healthcare Services
Conditions:
Breast Cancer Lymphedema
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether the addition of simple hand mobility and grip strengthening exercises to the usual care for upper extremity lymphedema will reduce limb volume and imp...
Detailed Description
The purpose of this study is to determine whether the addition of simple hand mobility and grip strengthening exercises to the usual care for upper extremity lymphedema will reduce limb volume and imp...
Eligibility Criteria
Inclusion
- Biologic women age 18 years or older with a diagnosis of clinical lymphedema of one upper extremity-early (clinical), moderate, or late stage, following treatment for breast cancer within the previous 10 years.
- Women concurrently receiving immunotherapy or chemotherapy are eligible for inclusion, but an additional information request may be necessary (e.g., any activity restrictions and nadir periods) to determine whether they can safely participate in the exercise activities and apply compression.
Exclusion
- Prior history of paresis in either upper limb, though paresis related to nerve compression from increased lymphatic volume will be eligible for inclusion.
- Current open wounds (\> 0.5 inch in length or diameter) of the axilla or edematous upper limb would be excluded, though the presence of lymphorrhea without visible skin tears will be eligible for inclusion.
- Previous treatment for upper limb lymphedema or a prior diagnosis of congestive heart failure or end-stage renal disease due to the impact on edematous limbs and risk of cardiac overload.
- Women who cannot speak or read English or Spanish sufficiently to complete the Lymphedema Life Impact Scale or understand the consent forms, educational information, and printed exercises will be excluded.
Key Trial Info
Start Date :
October 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05983380
Start Date
October 1 2023
End Date
December 30 2024
Last Update
April 17 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Presbyterian Healthplex
Albuquerque, New Mexico, United States, 87109
2
Presbyterian Southern Outpatient Rehab
Rio Rancho, New Mexico, United States, 87124
3
Presbyterian Santa Fe Medical Center
Santa Fe, New Mexico, United States, 87507